As mRNA Vaccine Production Expectations Increase, Samsung Biologics Invests in End-to-End Expertise
The use of mRNA vaccines to prevent COVID-19 infections was a turning point for the research and development of mRNA technology. COVID-19 vaccines produced by Moderna and Pfizer were the first mRNA vaccines approved for human use, and their demonstrated effectiveness has opened the floodgates for the future of mRNA vaccine production, with over 1,800 … Continue reading As mRNA Vaccine Production Expectations Increase, Samsung Biologics Invests in End-to-End Expertise
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed